Warning letter
ReConserve Inc.: warning letter of Jan 3, 2024
FDA warning letter 663413 · Division of Human and Animal Food Operations East II
Key facts
| Reference number | 663413 |
|---|---|
| Company | ReConserve Inc. |
| Subject | CGMP/Animal Food/Adulterated |
| Issue date | Jan 3, 2024 |
| Posted date | Jan 23, 2024 |
| Issuing office | Division of Human and Animal Food Operations East II |
| Product type | Veterinary |
| CFR sections cited | 507.40(c)(1), 507.17(c), 507.25(b)(1), 507.33(a), 507.47(b)(2), 507, 507.47(a), 507.3, 507.34, 507.50, 507.1(a)(1)(ii), 507.17(a)(1) |
| Inspection city | Baltimore |
| Inspection ZIP | 21226 |
| Inspection start date | May 23, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: